PAPNET

PAPNET

An automated neural net cervical smear test used to supplement smear examination by human pathologists. PAPNET checks every cell, comparing it with a normal standard. It then selects the 128 that are most abnormal and displays them on a monitor where they are checked by an expert. The system has been able to identify abnormal cells previously reported as normal up to 12 years before a positive diagnosis was reached.
References in periodicals archive ?
Observer variation in cytologic grading for cervical dysplasia of Papanicolaou smears with the PAPNET testing system," Cancer, 87(4): 178-183.
Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
For the American company who made the PAPNET test machine have gone bust.
In cytologic examinations, a semiautomated screening technology called PAPNET is under development.
is engaged in the business of acquiring, developing and marketing medical and health-related technologies, including the PAPNET test, which it markets in territories under exclusive license, and the OxyNet(R) oxygen concentration device which the company is developing for the home healthcare market.
The PAPNET test is a screening device for Pap smears that uses computer technology to extend the sensitivity of the manual Pap smear.
We remain convinced that PAPNET testing provides a robust, cost-effective and desirable method to improve the accuracy of Pap smear screening.
PAPNET testing is a computer-assisted method for screening slides from Pap smears and is designed to improve the detection of cervical cancer.
At present all manual screens are sent to NSI facilities for cnd health-related technologies, including the PAPNET test, which it markets in Ohio and other states underStatements which are not historical facts, including statements about the Company's confidence and strategies, its expectations about new and existing products, technologies and opportunities, market growth, demand for and acceptance of new and existing products (including the PAPNET(R) Testing System) and returns on investments are forward looking statements that involve risks and uncertainties.
AMEX: NMD), a developer and marketer of medical and health-related technologies, strongly restated its position that the PAPNET (R) test is an accurate and cost-effective method to screen for early signs of cervical cancer.
In the past, Mercy has performed PAPNET tests only when requested by a clinician.
Nearly 800,000 women in 16 countries on 6 continents have had their Pap smears screened using PAPNET testing.